TGF-β1 modulates podocyte migration by regulating the expression of integrin-β1 and -β3 through different signaling pathways
TGF-β1 inhibits integrin-β1 maturation through MAP kinases pathway, but increases integrin-β3 expression through Smad2/3 and MAP kinases pathways in podocytes. The increased integrin-β3 promotes podocyte adhesion and migration that may lead to foot process effacement. [Display omitted] •TGF-β1 and i...
Gespeichert in:
Veröffentlicht in: | Biomedicine & pharmacotherapy 2018-09, Vol.105, p.974-980 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | TGF-β1 inhibits integrin-β1 maturation through MAP kinases pathway, but increases integrin-β3 expression through Smad2/3 and MAP kinases pathways in podocytes. The increased integrin-β3 promotes podocyte adhesion and migration that may lead to foot process effacement.
[Display omitted]
•TGF-β1 and integrins regulate podocyte migration that can lead to foot process effacement, proteinuria and glomerulopathy.•TGF-β1 down-regulates the maturation of integrin-β1 and up-regulates the integrin-β3 through different pathways.•The increase in integrin-β3 expression promotes podocyte migration and adhesion.•This study identifies a novel mechanism for TGF-β1 signaling in regulating podocytes adhesion and migration.
Podocyte migration may lead foot process effacement and proteinuria. Transforming growth factor-β1 (TGF-β1) and integrins are involved in the adhesion and migration of cells. However, the crosstalk of TGF-β1 and integrins is unclear. Here, we examined how TGF-β1 regulates the expression of integrin-β1 and -β3 to modulate podocyte adhesion and migration.
Podocytes were exposed to TGF-β1 and/or the inhibitors of Smad2/3, ERK and p38, then the expression of integrin-β1 and -β3 was assessed by Real-time PCR and western blot analyses. Podocyte adhesion and migration were measured under TGF-β1 treatment and/or anti-integrin-β3 antibody by cell adhesion assay and wound healing assay.
TGF-β1 had no effect on integrin-β1 mRNA expression. In the analysis of protein expression, TGF-β1 decreased the mature form of integrin-β1, but increased both the precursor form and core peptide of integrin-β1. The inhibitors of ERK and p38, but not Smad2/3, abrogated TGF-β1-induced changes in integrin-β1 protein expression. TGF-β1 increased integrin-β3 mRNA and protein levels. The inhibitors of Smad2/3, ERK and p38 attenuated the TGF-β1-induced increase in integrin-β3 mRNA and protein levels. Podocyte adhesion and migration were enhanced under the stimulation of TGF-β1. The blockade of interactions between integrin-αvβ3 and the extracellular matrix by the anti-integrin-β3 antibody abrogated the TGF-β1-induced enhancement in podocyte adhesion and migration.
Our results demonstrate that TGF-β1up-regulates integrin-β3 expression and down-regulates integrin-β1 expression through different pathways. The up-regulation of integrin-β3 expression enhances podocyte migration. This study provides a novel mechanism for TGF-β1 signaling in regulating podocyte migration. |
---|---|
ISSN: | 0753-3322 1950-6007 |
DOI: | 10.1016/j.biopha.2018.06.054 |